Genes with higher levels of expression in MLBCL*
Gene class and specific genes . | Fold change† . |
---|---|
Cytokines and cytokine pathways | |
IL-13Rα1‡ | 1.9 |
JAK2‡ | 2.0 |
STAT1‡ | 1.7 |
Interleukin-4—induced gene 1 (FIG1)§ | 1.7 |
NF—IL-3‡ | 2.0 |
γIFN-inducible protein 10 (IP10/CXCR3 ligand)‡ | 2.0 |
γIFN-inducible protein 30 (IFI30/GILT) | 1.6 |
IFN-induced protein 35 | 1.5 |
RANTES (CCL5)‡ | 1.9 |
Chemokine receptor 1 (CCR1) | 1.5 |
RON (macrophage-stimulating 1 receptor/c-met—related TK) | 1.7 |
Interleukin-15 | 1.7 |
TNF family members and induced proteins | |
OX40 ligand (TNFSF4)‡ | 2.0 |
FAS ligand receptor/CD95 (TNFRSF6)‡§ | 1.7 |
Herpes virus entry mediator (HVEM, TNFRSF14) | 1.5 |
TRAF1‡ | 1.8 |
TNF-α—induced protein 3 (A20)‡ | 1.6 |
TNF-α—induced protein 6 | 2.3 |
Costimulatory molecules and inflammatory mediators | |
SLAM | 1.7 |
CD80 (B7.1)‡ | 1.4 |
CD86 (B7.2)‡ | 1.4 |
Cyclooxygenase 1 | 1.9 |
Prostaglandin receptor (IP) | 2.6 |
Cell adhesion molecules/extracellular matrix components | |
Fibroblast growth factor receptor-1 | 1.4 |
CD58 (lymphocyte-function associated antigen 3)‡§ | 1.5 |
Integrin α M (CD11b) | 1.8 |
Fibronectin | 3.0 |
Fibroblast activation protein α (seprase) | 2.0 |
Decorin | 2.0 |
Collagen type III α 1 | 2.1 |
Collagen type IV α 1 | 2.3 |
Collagen type IV α 2 | 1.6 |
Matrix metalloproteinase 14 | 2.0 |
Tissue inhibitor of metallo-proteinase 1‡ | 1.9 |
Other | |
MAL§ | 2.8 |
SNFT (Jun dimerization protein) | 2.8 |
Adenosine deaminase | 1.9 |
Gene class and specific genes . | Fold change† . |
---|---|
Cytokines and cytokine pathways | |
IL-13Rα1‡ | 1.9 |
JAK2‡ | 2.0 |
STAT1‡ | 1.7 |
Interleukin-4—induced gene 1 (FIG1)§ | 1.7 |
NF—IL-3‡ | 2.0 |
γIFN-inducible protein 10 (IP10/CXCR3 ligand)‡ | 2.0 |
γIFN-inducible protein 30 (IFI30/GILT) | 1.6 |
IFN-induced protein 35 | 1.5 |
RANTES (CCL5)‡ | 1.9 |
Chemokine receptor 1 (CCR1) | 1.5 |
RON (macrophage-stimulating 1 receptor/c-met—related TK) | 1.7 |
Interleukin-15 | 1.7 |
TNF family members and induced proteins | |
OX40 ligand (TNFSF4)‡ | 2.0 |
FAS ligand receptor/CD95 (TNFRSF6)‡§ | 1.7 |
Herpes virus entry mediator (HVEM, TNFRSF14) | 1.5 |
TRAF1‡ | 1.8 |
TNF-α—induced protein 3 (A20)‡ | 1.6 |
TNF-α—induced protein 6 | 2.3 |
Costimulatory molecules and inflammatory mediators | |
SLAM | 1.7 |
CD80 (B7.1)‡ | 1.4 |
CD86 (B7.2)‡ | 1.4 |
Cyclooxygenase 1 | 1.9 |
Prostaglandin receptor (IP) | 2.6 |
Cell adhesion molecules/extracellular matrix components | |
Fibroblast growth factor receptor-1 | 1.4 |
CD58 (lymphocyte-function associated antigen 3)‡§ | 1.5 |
Integrin α M (CD11b) | 1.8 |
Fibronectin | 3.0 |
Fibroblast activation protein α (seprase) | 2.0 |
Decorin | 2.0 |
Collagen type III α 1 | 2.1 |
Collagen type IV α 1 | 2.3 |
Collagen type IV α 2 | 1.6 |
Matrix metalloproteinase 14 | 2.0 |
Tissue inhibitor of metallo-proteinase 1‡ | 1.9 |
Other | |
MAL§ | 2.8 |
SNFT (Jun dimerization protein) | 2.8 |
Adenosine deaminase | 1.9 |
Gene list derived from the top 400 genes with higher levels of expression in MLBCL. All genes significant at P < .01
Fold change compared with DLBCL
Previously identified in Hodgkin Reed-Sternberg cells: IL-13R,23,24 JAK2,25,26 STAT1,27 NF—IL-3,28 IP10,29 RANTES,29 OX40L,30 CD95,30 TRAF1,31,32 A20,33 CD80,34 CD86,35 CD58,36 and TIMP1.37
Previously identified in MLBCL: FIG1,21 FAS/Apo1/CD95,38 MAL,8,39 and CD58.22,36